Last reviewed · How we verify
NCT06680219
Evaluation of the the Efficacy of a Digestive Health Supplement in Healthy Subjects
NA trial testing Placebo in Healthy Subjects in 50 participants. Completed in 31 August 2024.
30 June 2024
Quick facts
| Lead sponsor | Pharmanex |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 50 |
| Start date | 21 February 2024 |
| Primary completion | 30 June 2024 |
| Estimated completion | 31 August 2024 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Placebo
- Active comparator — full drug profile →
Conditions studied
- Healthy Subjects — all drugs for Healthy Subjects →
Sponsor
Pharmanex
Who can join
Adults 20 to 60, any sex, with Healthy Subjects. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to evaluate the efficacy of a digestive health supplement via waist circumference measurements, daily bowel habit and symptom logs, and self-perception questionnaires (SPQ) over 4 weeks. To test for the following claims: * Reduction of bloating after only one use. * SPQ claims - to be determined by the sponsor. * Improvement to a range of upper and lower gastrointestinal symptoms (heartburn, belching, bloating, nausea, vomiting, flatulence, intestinal cramps, urge to defecate, loose stool, and diarrhea) * Clinically proven formulation * Supports relief of bloating discomfort * Supports quick and effective reduction in bloating related to food intake * Study shows X% severity reduction in abdominal bloating * Helps support a reduction in days experiencing bloating * Supports a reduction in abdominal discomfort * X% of participants reported a reduction in bloating during the study * Supports a reduction in waist circumference, related to bloating Please note that it is the responsibility of the sponsor to determine the testing and study designs required for submission to entities such as the Home Shopping Network, QVC, etc.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06680219
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Active comparator
Trials testing the same drug.
- NCT07075588 — Integrating Free-choice Marketplace, dieTitian coacHing, cultuRally Tailored messagIng to improVE Blood Pressure · NA · not yet recruiting
- NCT07017244 — Effect of a Dietary Supplement vs Low-dosage Product on Infant Gastrointestinal Discomfort and Colics · NA · not yet recruiting
- NCT06830772 — Affective and Physiological Outcomes of Virtual and Mixed Reality Workplace Exergames · NA · completed
- NCT06714708 — Low Dose Radiotherapy Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Stage II-III NSCLC · Phase 2 · recruiting
- NCT07017296 — Microencapsulated Pomegranate Juice as Anti-Hypertensive · NA · completed
Other recruiting trials for Healthy Subjects
Currently open trials in the same condition.
- NCT07222020 — Phase 1 Study of Intravaginal KB15A · Phase 1 · recruiting
- NCT07350538 — The Critical Link Between Gut Microbiome Dysfunction, Cravings and Relapse: RECLAIM-GUT TRIAL · NA · active not recruiting
- NCT07304791 — This is a Phase 1, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Pharmacokinetics (PK), and P · Phase 1 · recruiting
- NCT07059858 — Bladder and Bowel Functions, Participation and Quality of Life in Children With Intellectual Disabilities · recruiting
- NCT07331389 — A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin · Phase 1 · recruiting
Other Pharmanex trials
Trials by the same sponsor.
- NCT07380438 — A Clinical Study to Evaluate the Efficacy of a Nutritional Supplement to Improve Carotenoid Content as Measured by a Non · NA · completed
- NCT05971771 — Study to Assess Impact of Dietary Supplement on Sleep Health · NA · unknown
- NCT06672965 — A Clinical Study to Evaluate the Efficacy of Dietary Supplement to Alleviate Stress Versus Placebo in Subjects with Mild · NA · completed
- NCT05041205 — Functional Test for a Drink Powder Alone and Combined Use With a Cosmetic Apparatus · NA · completed
- NCT04230824 — Chronic Study on Body Composition, Training, Performance, and Recovery · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06680219 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Pharmanex
- Last refreshed: 8 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06680219.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing